|
PIK3CA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.352090E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87647999999596E-05 |
| Normal-vs-Stage2 |
3.774100E-02 |
| Normal-vs-Stage3 |
4.272500E-02 |
| Normal-vs-Stage4 |
6.893800E-02 |
| Stage1-vs-Stage2 |
6.678800E-01 |
| Stage1-vs-Stage3 |
5.030000E-01 |
| Stage1-vs-Stage4 |
8.712000E-01 |
| Stage2-vs-Stage3 |
8.867600E-01 |
| Stage2-vs-Stage4 |
6.482800E-01 |
| Stage3-vs-Stage4 |
5.762400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.978740E-04 |
| Normal-vs-AfricanAmerican |
6.582500E-04 |
| Normal-vs-Asian |
2.998800E-03 |
| Caucasian-vs-AfricanAmerican |
6.348600E-01 |
| Caucasian-vs-Asian |
5.474800E-01 |
| AfricanAmerican-vs-Asian |
6.194400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2536000000285E-06 |
| Normal-vs-Female |
6.250600E-01 |
| Male-vs-Female |
2.301600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.710200E-02 |
| Normal-vs-Extreme_Weight |
1.60160000040044E-07 |
| Normal-vs-Obese |
1.267530E-02 |
| Normal-vs-Extreme_Obese |
9.316100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.879600E-01 |
| Normal_Weight-vs-Obese |
6.257000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.101600E-01 |
| Extreme_Weight-vs-Obese |
2.330400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.552200E-01 |
| Obese-vs-Extreme_Obese |
4.932600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.633800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.333850E-02 |
| Normal-vs-Age(61-80Yrs) |
1.59265999999381E-05 |
| Normal-vs-Age(81-100Yrs) |
3.87310000005137E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.003800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.552380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.360400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.845700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.223300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.117970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.35650000002252E-06 |
| Normal-VS-Type2 PRCC |
3.058800E-03 |
| Normal-VS-KIRP CIMP |
4.882200E-01 |
| Normal-VS-Unclassified PRCC |
6.190200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.585000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.240400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.477700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.212300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.581800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.902400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.27089999979857E-07 |
| Normal-vs-N1 |
5.891800E-01 |
| Normal-vs-N2 |
6.882000E-01 |
| N0-vs-N1 |
2.335800E-02 |
| N0-vs-N2 |
2.598800E-01 |
| N1-vs-N2 |
8.309600E-01 |
|
|
